Discontinuation report TARO-PREGABALIN
| Report ID | 144544 |
| Drug Identification Number | 02392852 |
| Brand name | TARO-PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 225MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-07-26 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-08-24 | French | Compare |
| v1 | 2021-08-24 | English | Compare |
Showing 1 to 2 of 2